Cipla Diclofenac Sodium Topical Gel Recall
Cipla's Diclofenac Sodium Topical Gel 1% (100 g) is being recalled because it failed pH specifications, which may affect the product's stability and …
Cipla USA, Inc.
Every recall we are tracking for Cipla USA, Inc., newest first, sourced from the FDA. If you are wondering whether your Cipla USA, Inc. product is recalled in 2026, check the list below for your model, lot, or VIN. Each entry explains the hazard and the free repair, replacement, or refund. Get a free email alert the moment a new Cipla USA, Inc. recall posts.
1 recall · updated Dec 22, 2025
Fresenius Kabi is recalling Naropin (ropivacaine hydrochloride injection) 0.5%, 20 mL single-dose vials because hair was found in some products. Use of …
Fresenius Kabi USA, LLC
Rohto Cooling Eye Drops Max Strength (0.4 FL OZ / 13 mL bottles) has been recalled because the manufacturer cannot confirm the product is sterile. Using …
Rohto-Mentholatum (Vietnam) Co., Ltd.
Rohto Cooling Eye Drops Cool Relief has been recalled because the manufacturer cannot guarantee the product is sterile. Use of non-sterile eye drops can lead to …
Rohto-Mentholatum (Vietnam) Co., Ltd.
Major Pharmaceuticals is recalling Levothyroxine Sodium 88 mcg tablets because they are subpotent, meaning they contain less active ingredient than labeled. …
Major Pharmaceuticals
Major Pharmaceuticals' Levothyroxine Sodium Tablets, USP 75 mcg, have been found to be subpotent, meaning they contain less active ingredient than stated. …
Major Pharmaceuticals
Major Pharmaceuticals is recalling Levothyroxine Sodium Tablets 150 mcg because some batches contain less active ingredient than labeled, which means they may …
Major Pharmaceuticals
Be the first to know if Cipla USA, Inc. issues a recall.
Free forever. Unsubscribe anytime. We never sell your data.